Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 879509, 5 pages
Research Article

Midkine: A Novel and Early Biomarker of Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions

12nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University, M. Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland
2Department of Invasive Cardiology, Medical University, M. Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland
3Department of Clinical Medicine, Medical University, Szpitalna 37, 15-254 Bialystok, Poland

Received 25 April 2014; Accepted 7 July 2014

Academic Editor: Alejandro Ferreiro

Copyright © 2015 Jolanta Malyszko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Elisabeta Bădilă, Ana Maria Daraban, Emma Ţintea, Daniela Bartoş, Nicoleta Alexandru, and Adriana Georgescu, “Midkine in cardio-vascular disease Where do we come from and where are we heading to?,” European Journal of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Michele Andreucci, Teresa Faga, Eleonora Riccio, Massimo Sabbatini, Antonio Pisani, and Ashour Michael, “The potential use of biomarkers in predicting contrast-induced acute kidney injury,” International Journal of Nephrology and Renovascular Disease, vol. 9, pp. 205–221, 2016. View at Publisher · View at Google Scholar
  • Hiroki Hayashi, Waichi Sato, Tomoki Kosugi, Kunihiro Nishimura, Daisuke Sugiyama, Naoko Asano, Shinya Ikematsu, Kimihiro Komori, Kimitoshi Nishiwaki, Kenji Kadomatsu, Seiichi Matsuo, Shoichi Maruyama, and Yukio Yuzawa, “Efficacy of urinary midkine as a biomarker in patients with acute kidney injury,” Clinical and Experimental Nephrology, 2016. View at Publisher · View at Google Scholar
  • Delia Lidia Şalaru, Cătălina Arsenescu-Georgescu, Christos Chatzikyrkou, Jaqueline Karagiannis, Anja Fischer, and Peter R. Mertens, “Midkine, a heparin-binding growth factor, and its roles in atherogenesis and inflammatory kidney diseases,” Nephrology Dialysis Transplantation, pp. gfw083, 2016. View at Publisher · View at Google Scholar
  • Michele Andreucci, Teresa Faga, Antonio Pisani, Maria Perticone, and Ashour Michael, “The ischemic/nephrotoxic Acute Kidney Injury and the use of renal biomarkers in clinical practice,” European Journal of Internal Medicine, 2016. View at Publisher · View at Google Scholar
  • Zhantao Su, Xin Lv, Yi Liu, Jinhang Zhang, Jingyun Guan, and Zhongtao Gai, “Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications,” International Immunopharmacology, vol. 39, pp. 246–250, 2016. View at Publisher · View at Google Scholar
  • Victoria K. Campbell, Sharron T Hall, Dominic Burg, Drew C Comeau, Euan P Noble, Kumar Mahadevan, Peter R Hollett, Andrea J Pollock, Darren R Jones, Nicholas A Gray, Chris M Anstey, Ryan P Gately, and Carolyn J Clark, “Urine and serum midkine levels in an Australian chronic kidney disease clinic population: An observational study,” BMJ Open, vol. 7, no. 9, 2017. View at Publisher · View at Google Scholar
  • Peter S Hall, Elizabeth D Mitchell, Alison F Smith, David A Cairns, Michael Messenger, Michelle Hutchinson, Judy Wright, Karen Vinall-Collier, Claire Corps, Patrick Hamilton, David Meads, and Andrew Lewington, “The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation,” Health Technology Assessment, vol. 22, no. 32, pp. 1–274, 2018. View at Publisher · View at Google Scholar